Sanctuary Advisors LLC lowered its holdings in Utah Medical Products, Inc. (NASDAQ:UTMD – Free Report) by 4.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,998 shares of the medical instruments supplier’s stock after selling 268 shares during the period. Sanctuary Advisors LLC owned 0.18% of Utah Medical Products worth $392,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in UTMD. Martingale Asset Management L P lifted its holdings in shares of Utah Medical Products by 5.3% during the 3rd quarter. Martingale Asset Management L P now owns 3,968 shares of the medical instruments supplier’s stock worth $266,000 after acquiring an additional 201 shares during the period. Bard Associates Inc. raised its stake in Utah Medical Products by 1.1% during the third quarter. Bard Associates Inc. now owns 19,781 shares of the medical instruments supplier’s stock worth $1,329,000 after purchasing an additional 224 shares during the period. BNP Paribas Financial Markets boosted its holdings in shares of Utah Medical Products by 102.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after purchasing an additional 566 shares during the last quarter. State Street Corp grew its stake in shares of Utah Medical Products by 0.9% during the 3rd quarter. State Street Corp now owns 80,856 shares of the medical instruments supplier’s stock valued at $5,434,000 after buying an additional 694 shares during the period. Finally, Copeland Capital Management LLC acquired a new stake in shares of Utah Medical Products during the 3rd quarter worth $53,000. 69.60% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Separately, StockNews.com downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th.
Utah Medical Products Stock Up 0.2 %
Shares of UTMD stock opened at $61.58 on Friday. Utah Medical Products, Inc. has a fifty-two week low of $60.39 and a fifty-two week high of $87.00. The firm’s 50 day moving average price is $64.58 and its two-hundred day moving average price is $66.44. The stock has a market cap of $208.88 million, a price-to-earnings ratio of 14.42 and a beta of 0.08.
Utah Medical Products Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, January 3rd. Investors of record on Monday, December 16th will be issued a $0.305 dividend. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 1.98%. The ex-dividend date of this dividend is Monday, December 16th. Utah Medical Products’s dividend payout ratio is currently 28.57%.
About Utah Medical Products
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Stories
- Five stocks we like better than Utah Medical Products
- How to Buy Cheap Stocks Step by Step
- Top 3 Investment Themes to Watch for in 2025
- Financial Services Stocks Investing
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- How to Find Undervalued Stocks
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD – Free Report).
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.